Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl) urea

EU orphan designation number: EU/3/07/517
Active ingredient: N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl) urea
Indication: Treatment of hepatocellular carcinoma
Sponsor: AbbVie Ltd
Abbvie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4UB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/12/2007 Orphan designation EMEA/OD/090/07 (2007)6812 of 20/12/2007
08/02/2013 Transfer of orphan designation EMA/OD/090/07/T/01 (2013)732 of 06/02/2013
18/01/2016 Change of name and/or address of sponsor
29/01/2016 Removal of orphan designation from Community Register